This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

H. L. HOFFMAN, M.D.; J. JACOBS, M.D.; S. O. FREEDLANDER, M.D.

AMA Arch Surg. 1953;66(5):617-623.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ISOLATION of crystalline soybean trypsin inhibitor by Kunitz¹ in 1946 suggested the use of this material in the treatment of acute hemorrhagic pancreatitis.

Coffee, Brinig, and Gillespie,² in 1950, while studying the abnormal tryptic activity of the blood in acute pancreatic necrosis, reported that the antitryptic index of the blood serum, carried out by the gelatin-digestion method, was significantly lowered both in experimental and in clinical pancreatic necrosis. In contrast, there was no change from the normal levels in pancreatic edema. The antitryptic index could be depressed by the use of crystalline soybean trypsin inhibitor. In this work, the antitrypsin appeared to protect small animals against toxic doses of trypsin and to modify the course of experimentally produced pancreatic peritonitis.

Rush and Cliffton,³ in 1951, in experiments on 12 dogs used soybean trypsin inhibitor in 3 of these animals with experimentally produced pancreatitis and concluded that . . . [Full Text PDF of this Article]

Author Affiliations
CLEVELAND

From the Katz-Sanders Surgical Research Laboratory, Mt. Sinai Hospital.

Footnotes
The technical assistance of Miss Kay Fowler is acknowledged.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?